object
sever
acut
respiratori
syndrom
sar
acut
infecti
diseas
respiratori
system
newli
emerg
interestingli
appear
diseas
predominantli
affect
adult
mortal
children
extrem
low
howev
pathogenesi
sar
relat
differ
characterist
relev
age
remain
unclear
materi
method
better
understand
role
cytokin
immunopatholog
process
sar
weanl
week
old
young
week
old
adult
week
old
male
balbc
mice
inocul
intranas
nprotein
sarscov
studi
serum
lung
homogen
level
cytokin
tumor
necrosi
factora
tnfa
interferong
ifng
along
acut
injuri
lung
index
histolog
also
analyz
result
histopatholog
analysi
adult
male
balb
c
mice
nprotein
infect
show
progress
inflammatori
reaction
especi
pulmonari
edema
accord
moder
elev
level
wd
ratio
h
although
adult
group
underw
progress
lung
inflamm
acut
phase
accompani
rais
level
tnfa
serum
signific
chang
lung
tnfa
level
report
simultan
moreov
adult
sar
infect
balbc
mice
show
elev
level
ifng
ifng
level
weanl
young
group
obviou
associ
lung
inflamm
conclus
studi
support
observ
adult
mice
progress
greater
immun
reaction
weanl
adolesc
one
time
rel
immatur
immun
system
weanl
may
confer
benefit
lead
less
impair
lung
function
howev
measur
tnfa
ifng
level
indic
sever
lung
injuri
earli
stage
diseas
sever
acut
respiratori
syndrom
sar
acut
infecti
diseas
respiratori
system
new
infecti
diseas
signific
morbid
mortal
whose
major
clinic
featur
includ
persist
fever
chillsrigor
myalgia
malais
dri
cough
headach
dyspnoea
interestingli
wreak
havoc
china
south
east
asia
part
world
appear
diseas
predominantli
affect
adult
less
infect
children
among
affect
children
requir
admiss
intens
care
unit
less
requir
mechan
ventil
death
report
among
children
affect
sar
differ
featur
children
led
believ
sar
rel
mild
diseas
age
group
novel
coronaviru
identifi
pathogen
respons
sar
howev
pathogenesi
sar
involv
differ
charact
relev
age
remain
unclear
effici
treatment
sar
far
previou
studi
show
sarscov
contain
variabl
region
repres
code
sequenc
viral
structur
gene
spike
protein
envelop
e
protein
membran
protein
nucleocapsid
n
protein
cooh
terminu
n
protein
could
extrem
antigen
among
coronaviru
protein
n
protein
abund
throughout
infect
mrna
protein
level
recent
sever
studi
anim
demonstr
n
protein
could
induc
specif
tcell
respons
observ
coronavirus
also
prove
cellular
immun
respons
n
protein
coronaviru
gener
protect
effect
studi
investig
differ
manifest
lung
inflamm
caus
n
protein
sarscov
mice
clinic
manifest
chest
radiograph
patholog
featur
patient
sar
similar
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
immunopatholog
injuri
host
cell
trigger
immun
respons
viru
play
key
role
pathogenesi
sar
determin
cytokin
involv
cell
damag
develop
organ
dysfunct
aid
understand
immunopatholog
process
sar
shown
mani
proinflammatori
cytokin
tumor
necrosi
factora
tnfa
interferong
ifng
take
part
occurr
develop
ali
ard
therapi
aim
directli
cytokin
achiev
initi
effect
tnfa
shown
elev
bronchopulmonari
secret
patient
adult
respiratori
distress
syndrom
caus
pulmonari
inflammatori
reaction
administ
intraven
directli
lung
anim
although
product
tnfa
found
increas
correl
posit
sever
infect
swine
pneumonia
studi
show
plasma
tnfa
elev
sar
patient
suggest
host
immun
reaction
novel
coronaviru
might
dif
ferent
immun
reaction
pathogen
besid
imbal
cytokin
profil
confirm
sarscov
induc
predomin
sar
patient
exhibit
signific
increas
typic
antivir
cytokin
ifng
array
proinflammatori
cytokin
studi
show
chemokin
ifnginduc
monokin
induc
interferong
substanti
boost
soon
onset
fever
pediatr
case
howev
still
controversi
uncertainti
express
pattern
cytokin
develop
sar
especi
earli
stage
diseas
among
differ
age
understand
role
cytokin
immunopatholog
process
sar
better
cytokin
profil
serum
lung
homogen
level
defin
stage
differ
age
analyz
besid
leukocyt
count
wetdri
ratio
lung
tissu
histolog
also
examin
administr
weanl
week
old
young
week
old
adult
week
old
male
balbc
mice
obtain
depart
anim
husbandri
shanghai
medic
school
fudan
univers
anim
hous
six
mice
per
standard
cage
specifi
pathogenfre
environ
mice
maintain
hr
light
dark
cycl
receiv
water
food
ad
libitum
experi
approv
experiment
anim
ethic
committe
fudan
univers
mice
rang
age
randomli
assign
two
group
anim
experi
group
anesthet
ethyleth
inocul
intranas
dose
mgkg
volum
mlkg
nprotein
sar
deriv
serum
sar
patient
fudan
yueda
biotech
co
ltd
normal
control
mice
inocul
intranas
volum
sodium
chlorid
group
three
subset
repres
three
observ
time
point
hour
administr
mice
subset
individu
mice
surviv
multipl
blood
withdraw
subset
mice
reanesthet
ethyleth
sacrif
exsanguin
anim
studi
perform
period
evalu
white
blood
cell
count
wetdri
ratio
lung
tissu
blood
collect
immedi
sacrific
sampl
withdrawn
dissolv
glacial
acet
acid
white
blood
cell
count
sera
separ
centrifug
minut
test
right
lobe
lung
tissu
obtain
weigh
immedi
hour
store
oven
determin
wetdri
ratio
lung
tissu
lower
left
lobe
lung
homogen
cold
phosphat
buffer
salin
preserv
ice
bath
use
lung
homogen
centrifug
minut
supern
sera
mention
store
treatment
tnfa
ifng
lung
homogen
determin
commerci
avail
enzymelink
immunosorb
assay
kit
accord
manufactur
instruct
shanghai
senxiong
corp
result
normal
total
amount
protein
measur
biorad
protein
assay
biorad
laboratori
shanghai
medic
school
fudan
univers
valu
present
mean
ae
sd
signific
differ
nprotein
group
control
group
p
tnfa
ifng
sera
also
determin
commerci
avail
enzymelink
immunosorb
assay
kit
method
mention
upper
left
lobe
lung
collect
fix
histolog
assess
tissu
subsequ
embed
wv
formalin
solut
buffer
phosphat
buffer
salin
fivemicron
section
lung
stain
hematoxylin
eosin
evalu
experienc
pathologist
unawar
anim
group
use
light
microscopi
chang
parenchyma
grade
scale
normal
sever
congest
edema
inflamm
grade
subscor
compil
total
histopatholog
score
hp
total
hp
assign
valu
higher
score
greater
inflammatori
chang
lung
statist
analysi
data
express
mean
ae
sem
oneway
analysi
varianc
use
determin
statist
signific
among
multi
group
test
use
comparison
two
group
data
analyz
use
spss
system
p
valu
consid
signific
infect
young
balbc
mice
nprotein
sarscov
ae
result
elev
level
leukocyt
count
peripher
blood
compar
control
group
ae
collect
hour
administr
p
tabl
although
moder
elev
level
wd
ratio
adult
mice
observ
follow
inocul
nprotein
ae
compar
control
group
ae
hour
later
p
signific
differ
seen
control
infect
mice
weanl
young
group
check
express
profil
tnfa
respons
nprotein
sarscov
differ
age
tnfa
assay
serum
well
homogen
sampl
compar
control
group
ae
concentr
serum
tnfa
increas
weanl
group
ae
hour
exposur
nprotein
likewis
level
adult
group
ae
also
rose
significantli
compar
ns
normal
salin
group
ae
figur
level
serum
tnfa
weanl
group
obvious
increas
hour
young
group
adult
group
slightli
decreas
respect
howev
increas
adult
group
much
higher
weanl
group
young
group
respect
figur
compar
control
group
ae
protein
concentr
homogen
tnfa
appar
decreas
weanl
group
ae
mg
protein
hour
exposur
nprotein
level
homogen
tnfa
hour
ae
protein
hour
ae
protein
hour
ae
protein
notabl
boost
compar
h
ae
protein
h
protein
h
protein
ns
group
respect
respect
figur
increas
homogen
tnfa
young
group
higher
weanl
group
hour
exposur
nprotein
hour
increment
young
group
much
higher
two
group
respect
besid
chang
adult
group
also
greater
weanl
group
figur
address
specif
ifng
profil
repres
differ
stage
lifeperiod
follow
inocul
nprotein
investig
categori
sampl
tnfa
compar
control
group
ae
concentr
serum
ifng
decreas
young
group
ae
hour
exposur
nprotein
addit
level
weanl
group
ae
also
decreas
compar
ns
group
ae
adult
group
ae
rais
compar
ns
group
ae
respect
figur
increas
serum
ifng
weanl
group
consider
higher
young
group
hour
nevertheless
increas
young
group
adult
group
much
higher
weanl
group
respect
figur
concentr
homogen
ifng
rais
young
ae
protein
adult
group
ae
protein
hour
exposur
n
figur
increas
homogen
ifng
young
adult
group
much
higher
weanl
group
hour
respect
figur
histopatholog
chang
score
congest
inflamm
edema
tabl
score
categori
higher
nprotein
group
compar
control
group
weanl
hour
intranas
inocul
nprotein
recurr
also
found
hour
period
relief
addit
progress
increas
score
display
hour
young
howev
statist
signific
differ
found
weanl
young
except
score
congest
hour
young
earli
stage
score
slightli
higher
nprotein
group
versu
control
group
hour
adult
show
strong
increas
trend
time
score
categori
significantli
higher
hour
total
histopatholog
score
calcul
tabl
result
remark
higher
score
nprotein
versu
control
group
hour
adult
statist
higher
score
hour
young
also
seen
figur
percentag
increas
ifng
homogen
compar
nprotein
group
control
group
signific
differ
young
group
weanl
group
p
signific
differ
adult
group
weanl
group
p
signific
differ
adult
group
young
group
p
goal
examin
chang
earli
stage
lung
inflamm
caus
n
protein
sarscov
among
differ
age
group
balbc
mice
small
access
infect
nprotein
sarscov
evalu
extens
immunolog
level
sever
lab
possibl
anim
model
sar
seem
rout
inocul
key
factor
demonstr
sarscov
replic
mice
subbarao
et
al
demonstr
sarscov
infect
balbc
mice
intranas
inocul
mice
exhibit
mild
focal
peribronchiolar
mononuclear
inflammatori
infiltr
signific
patholog
organ
previou
studi
confirm
anim
show
acut
lung
injuri
hour
inocul
nprotein
suggest
mice
infect
nprotein
mimick
immunopatholog
process
sar
short
term
studi
inflammatori
histopatholog
chang
lung
present
anim
hour
follow
administr
gener
human
exhibit
matur
lung
birth
rodent
alveolar
rodent
occur
exclus
day
birth
thorac
growth
alveolar
persist
throughout
life
mice
wean
approxim
week
old
alveolar
wall
form
test
male
mice
drop
scrotum
day
old
studi
balbc
mice
age
week
old
chosen
analog
period
childhood
adolesc
adult
human
respect
epidemiolog
studi
sar
outbreak
show
advanc
age
risk
factor
advers
outcom
sar
lung
inflamm
caus
sarscov
like
complex
pathophysiolog
process
involv
inflammatori
cytokin
releas
activ
macrophag
alveoli
lead
immun
system
dysregul
predomin
patholog
lung
patient
infect
sarscov
demonstr
diffus
alveolar
damag
dad
studi
histopatholog
analysi
adult
male
balbc
mice
nprotein
infect
show
progress
inflammatori
reaction
especi
pulmonari
edema
accord
moder
elev
level
wd
ratio
hour
loss
cilia
denud
bronchiolar
epithelium
lumin
deposit
fibrin
provid
evid
sever
injuri
bronchiolar
epithelium
adult
weanl
young
mice
interestingli
observ
pulmonari
inflamm
congest
occur
immedi
intranas
inocul
nprotein
weanl
group
recurr
found
hour
period
relief
also
found
lung
injuri
becam
progress
wors
hour
young
group
lessen
howev
signific
differ
either
wd
ratio
histopatholog
score
seen
control
infect
mice
weanl
young
group
except
hour
young
report
dicat
inflamm
lung
would
becom
aggrav
patient
name
second
peak
one
possibl
explan
attribuet
secondari
virema
other
propos
secondari
immun
respons
relat
infect
viru
may
play
import
role
mice
weanl
group
underw
similar
process
differ
two
group
suggest
acut
immunopatholog
develop
diseas
earli
stage
weanl
time
point
need
assess
investig
whether
older
group
process
time
immunopatholog
injuri
host
cell
trigger
immun
respons
viru
play
key
role
pathogenesi
viru
infect
mani
cytokin
releas
activ
immun
cell
take
part
process
antivir
immun
respons
also
involv
cell
damag
develop
organ
dysfunct
pak
c
et
al
report
tnfa
mildli
rais
initi
phase
ill
children
interestingli
progress
level
tnfa
serum
adult
sar
patient
report
beij
group
nation
research
project
sar
result
show
level
tnfa
focal
lung
tissu
young
group
much
higher
two
group
earli
stage
diseas
young
group
present
rel
sever
transient
circumscrib
lung
injuri
hour
although
adult
group
underw
progress
lung
inflamm
acut
phase
accompani
rais
level
tnfa
serum
signific
chang
lung
tnfa
level
report
simultan
rais
question
whether
measur
tnfa
level
reflect
sever
lung
injuri
earli
stage
sar
disequilibrium
immunolog
system
caus
imbal
cytokin
probabl
one
critic
pathogen
mechan
sar
proven
level
ifng
proinflammatori
cytokin
significantli
advanc
earli
stage
sar
even
decreas
convalesc
stage
studi
adult
sar
infect
balbc
mice
show
elev
level
ifng
suggest
proinflammatori
cytokin
respons
may
respons
sarsassoci
event
howev
ifng
level
weanl
young
group
obviou
associ
lung
inflamm
possibl
reason
propos
includ
weanl
mice
abl
mount
heighten
matur
immun
respons
seen
adult
immun
deregul
phase
sar
thu
less
organ
damag
ensu
associ
morbid
mortal
also
confirm
research
increment
wd
ratio
weanl
group
signific
adult
group
addit
leung
cw
et
al
pose
viewpoint
children
gener
present
less
comorbid
adult
may
contribut
low
mortal
children
moreov
role
cytokin
except
tnfa
ifng
immunopatholog
process
diseas
especi
earli
stage
remain
undetermin
limit
amount
specimen
conclus
studi
support
observ
adult
mice
progress
greater
immun
reaction
weanl
adolesc
anim
time
rel
immatur
immun
system
weanl
may
confer
benefit
lead
less
impair
lung
function
howev
measur
tnfa
ifng
level
seem
indic
sever
lung
injuri
earli
stage
diseas
